Systemic Inflammation: Clinical Trials

2 trials for Systemic Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Systemic Inflammation: new trials by email Literature Review of Systemic Inflammation trials Research Report on Systemic Inflammation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
Single-Dose IV Oritavancin Diphosphate, IV Vancomycin, Placebo - Wound Infection, Abscess
Phase 3CompletedMelinta Therapeutics, Inc.9682010-12-012022-08-01
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
Single-Dose IV Oritavancin Diphosphate, IV Vancomycin - Wound Infection, Abscess
Phase 3CompletedMelinta Therapeutics, Inc.10192010-12-012021-05-05

Narrower conditions

Abscess (2)  ·  Cellulitis (2)  ·  Wound Infection (2)

Broader conditions

Connective Tissue Diseases (2)  ·  Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases, Infectious (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Suppuration (2)

Interventions

Vancomycin (2)

Sponsors

Melinta Therapeutics, Inc. (2)

Countries

United States (2)

Top investigators

G. Ralph Corey, MD (2)

Results publications

PMID 27370913, PMID 29358292, PMID 24897083, PMID 25294250